Free Trial

Pulmatrix (PULM) Short Interest Ratio & Short Volume

Pulmatrix logo
$5.40 -0.56 (-9.40%)
Closing price 04/4/2025 03:59 PM Eastern
Extended Trading
$5.42 +0.02 (+0.46%)
As of 04/4/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pulmatrix Short Interest Data

Pulmatrix (PULM) has a short interest of 37,900 shares, representing 1.04% of the float (the number of shares available for trading by the public). This marks a 9.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 132,655 shares to cover all short positions.

Current Short Interest
37,900 shares
Previous Short Interest
34,600 shares
Change Vs. Previous Month
+9.54%
Dollar Volume Sold Short
$320,634.00
Short Interest Ratio
1.1 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
3,650,000 shares
Float Size
3,650,000 shares
Short Percent of Float
1.04%
Today's Trading Volume
36,849 shares
Average Trading Volume
132,655 shares
Today's Volume Vs. Average
28%
Short Selling Pulmatrix?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Pulmatrix and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PULM Short Interest Over Time

PULM Days to Cover Over Time

PULM Percentage of Float Shorted Over Time

Remove Ads

Pulmatrix Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/202537,900 shares $320,634.00 +9.5%1.0%1.1 $8.46
2/28/202534,600 shares $279,568.00 -10.4%1.0%0.7 $8.08
2/15/202538,600 shares $298,378.00 -27.0%1.1%0.5 $7.73
1/31/202552,900 shares $407,330.00 +10.9%1.5%0.1 $7.70
1/15/202547,700 shares $283,338.00 +20.8%1.3%0.1 $5.94
12/31/202439,500 shares $275,710.00 -47.3%1.1%0.1 $6.98
12/15/202474,900 shares $430,675.00 +27.8%2.1%0.2 $5.75
11/30/202458,600 shares $389,104.00 -85.8%1.6%0.1 $6.64
11/15/2024411,600 shares $2.70 million +5,697.2%11.3%1 $6.56
10/31/20247,100 shares $15,620.00 +9.2%0.2%0.6 $2.20
10/15/20246,500 shares $13,585.00 +27.5%0.2%0.6 $2.09
9/30/20245,100 shares $10,914.00 -20.3%0.1%0.5 $2.14
9/15/20246,400 shares $12,864.00 +25.5%0.2%0.5 $2.01
8/31/20245,100 shares $10,557.00 -37.0%0.1%0.5 $2.07
8/15/20248,100 shares $17,241.66 -31.4%0.2%0.7 $2.13
7/31/202411,800 shares $25,606.00 +126.9%0.3%1.1 $2.17
7/15/20245,200 shares $10,680.80 +372.7%0.1%0.5 $2.05
6/30/20241,100 shares $2,123.00 +120.0%0.0%0.1 $1.93
6/15/2024500 shares $958.85 -77.3%0.0%0 $1.92
5/31/20242,200 shares $4,114.00 +450.0%0.1%0.2 $1.87
5/15/2024400 shares $732.00 -86.2%0.0%0 $1.83
4/30/20242,900 shares $5,510.29 -74.8%0.1%0.2 $1.90
4/15/202411,500 shares $24,035.00 +325.9%0.3%0.7 $2.09
3/31/20242,700 shares $4,725.00 +575.0%0.1%0.2 $1.75
3/15/2024400 shares $672.00 -97.4%0.0%0 $1.68
2/29/202415,300 shares $30,447.00 +91.3%0.4%0.9 $1.99
2/15/20248,000 shares $14,720.00 +27.0%0.2%0.4 $1.84
1/31/20246,300 shares $10,899.00 +350.0%0.2%0.4 $1.73
1/15/20241,400 shares $2,741.20 -68.2%0.0%0.1 $1.96
12/31/20234,400 shares $8,184.00 -44.3%0.1%0.3 $1.86
12/15/20237,900 shares $14,931.00 +27.4%0.2%0.6 $1.89
11/30/20236,200 shares $12,772.00 +195.2%0.2%0.6 $2.06
11/15/20232,100 shares $3,780.00 -38.2%0.1%0.2 $1.80
10/31/20233,400 shares $6,426.00 -12.8%0.1%0.3 $1.89
10/15/20233,900 shares $7,927.92 -20.4%0.1%0.3 $2.03
9/30/20234,900 shares $9,947.00 +14.0%0.1%0.4 $2.03
9/15/20234,300 shares $9,847.00 +59.3%0.1%0.3 $2.29
8/31/20232,700 shares $6,345.00 -20.6%0.1%0.2 $2.35
8/15/20233,400 shares $8,551.00 +88.9%0.1%0.2 $2.52
7/31/20231,800 shares $4,770.00 -45.5%0.1%0.1 $2.65
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)

Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.

There's no time to waste. As far as I can tell, the best way to profit from this project is to make
7/15/20233,300 shares $8,943.00 -41.1%0.1%0.2 $2.71
6/30/20235,600 shares $15,008.00 -47.2%0.2%0.4 $2.68
6/15/202310,600 shares $29,362.00 +120.8%0.3%0.7 $2.77
5/31/20234,800 shares $13,102.56 +29.7%0.1%0.3 $2.73
5/15/20233,700 shares $9,953.00 +184.6%0.1%0.2 $2.69
4/30/20231,300 shares $3,821.22 -55.2%0.0%0.1 $2.94
4/15/20232,900 shares $8,613.00 No Change0.1%0.1 $2.97
3/31/20232,900 shares $8,468.00 -64.2%0.1%0.1 $2.92
3/15/20238,100 shares $25,272.00 -13.8%0.2%0.2 $3.12
2/28/20239,400 shares $32,427.18 -36.5%0.3%0.2 $3.45
2/15/202314,800 shares $55,500.00 -56.7%0.4%0.4 $3.75
1/31/202334,200 shares $137,826.00 -24.7%0.9%0.9 $4.03
1/15/202345,400 shares $196,582.00 +17.0%1.3%1.2 $4.33
12/30/202238,800 shares $150,544.00 -7.2%1.1%1 $3.88
12/15/202241,800 shares $156,332.00 +3.0%1.2%2 $3.74
11/30/202240,600 shares $151,844.00 -21.2%1.1%1.7 $3.74
11/15/202251,500 shares $201,880.00 -1.9%1.4%0.6 $3.92
10/31/202252,500 shares $180,600.00 -19.9%1.6%0.6 $3.44
10/15/202265,500 shares $235,145.00 -24.2%1.9%0.5 $3.59
9/30/202286,400 shares $308,448.00 -17.2%2.6%0.7 $3.57
9/15/2022104,400 shares $463,536.00 -28.4%3.1%0.8 $4.44
8/31/2022145,700 shares $643,994.00 +840.0%4.3%1.2 $4.42
8/15/202215,500 shares $73,625.00 -1.3%0.5%0.2 $4.75
7/31/202215,700 shares $69,080.00 +36.5%0.5%0.3 $4.40
7/15/202211,500 shares $52,440.00 +6.5%0.3%0.7 $4.56
6/30/202210,800 shares $49,572.00 -44.0%0.3%0.7 $4.59
6/15/202219,300 shares $85,692.00 +10.3%0.6%1 $4.44
5/31/202217,500 shares $94,500.00 -23.3%0.5%0.6 $5.40
5/15/202222,800 shares $117,192.00 -17.7%0.7%0.5 $5.14
4/30/202227,700 shares $141,547.00 -74.4%0.8%0.6 $5.11
4/15/2022108,000 shares $640,440.00 -20.0%3.3%2.1 $5.93
3/31/2022135,000 shares $922,050.00 +40.5%4.1%2.5 $6.83
3/15/202296,100 shares $580,444.00 +359.8%3.0%1.4 $6.04
2/28/202220,900 shares $129,162.00 -92.1%0.6%0.3 $6.18
2/15/2022265,900 shares $96,787.60 -20.7%N/A0.2 $0.36
1/31/2022335,400 shares $132,483.00 -23.1%N/A0.3 $0.40
1/15/2022436,400 shares $174,123.60 -80.6%0.8%0.4 $0.40
12/31/20212,250,000 shares $985,500.00 +162.2%4.1%2 $0.44
12/15/2021858,100 shares $416,178.50 -16.7%1.6%0.9 $0.49
11/30/20211,030,000 shares $687,010.00 -20.2%1.9%1.9 $0.67
11/15/20211,290,000 shares $1.05 million +1.6%2.3%2.5 $0.81
10/29/20211,270,000 shares $1.10 million +9.5%2.3%2.7 $0.87
10/15/20211,160,000 shares $842,160.00 -4.9%2.1%4.3 $0.73
9/30/20211,220,000 shares $976,000.00 +6.1%2.2%4 $0.80
9/15/20211,150,000 shares $888,950.00 +9.5%2.1%3.5 $0.77
8/31/20211,050,000 shares $860,895.00 +13.8%1.9%2.8 $0.82
8/13/2021922,900 shares $719,862.00 +13.7%1.7%2 $0.78
7/30/2021811,900 shares $685,893.12 +28.4%1.5%1.5 $0.84
7/15/2021632,500 shares $548,567.25 -14.3%1.1%1 $0.87
6/30/2021737,600 shares $767,104.00 -2.1%1.3%0.9 $1.04
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)

Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.

There's no time to waste. As far as I can tell, the best way to profit from this project is to make
6/15/2021753,400 shares $768,468.00 -9.3%1.4%0.9 $1.02
5/28/2021830,600 shares $772,873.30 -17.8%1.5%0.8 $0.93
5/14/20211,010,000 shares $839,108.00 -8.2%N/A0.7 $0.83
4/30/20211,100,000 shares $1.11 million +39.4%N/A0.4 $1.01
4/15/2021788,900 shares $812,567.00 -37.9%N/A0.3 $1.03
3/31/20211,270,000 shares $1.65 million -8.6%N/A0.5 $1.30
3/15/20211,390,000 shares $2.10 million +3.7%N/A0.5 $1.51
2/26/20211,340,000 shares $2.18 million +28.9%N/A0.6 $1.63
2/12/20211,040,000 shares $2.09 million +1,014.7%N/A0.5 $2.01
1/29/202193,300 shares $137,151.00 +148.1%N/A0.1 $1.47
1/15/202137,600 shares $47,752.00 -83.7%N/A0.1 $1.27
12/31/2020230,900 shares $277,080.00 +162.4%N/A0.4 $1.20
12/15/202088,000 shares $116,160.00 -66.3%N/A0.2 $1.32
11/30/2020261,400 shares $334,592.00 +187.9%N/A0.6 $1.28
11/15/202090,800 shares $103,512.00 -73.9%N/A0.2 $1.14
10/30/2020348,100 shares $362,024.00 +56.7%N/A0.8 $1.04
10/15/2020222,100 shares $257,636.00 +87.7%N/A0.4 $1.16
9/30/2020118,300 shares $140,777.00 +20.8%N/A0.2 $1.19
9/15/202097,900 shares $116,501.00 -6.1%N/A0.1 $1.19
8/31/2020104,300 shares $111,601.00 -53.7%N/A0.1 $1.07
8/14/2020225,100 shares $263,367.00 -59.7%N/A0.3 $1.17
7/31/2020558,800 shares $737,616.00 +61.7%N/A0.6 $1.32
7/15/2020345,600 shares $463,104.00 -79.4%N/A0.3 $1.34
6/30/20201,680,000 shares $2.89 million +22.6%N/A1.4 $1.72
6/15/20201,370,000 shares $2.11 million -8.7%N/A1.2 $1.54
5/29/20201,500,000 shares $2.57 million -20.6%N/A1.4 $1.71
5/15/20201,890,000 shares $2.87 million +43.2%N/A1.7 $1.52
4/30/20201,320,000 shares $1.82 million -19.0%7.1%1.3 $1.38
4/15/20201,630,000 shares $2.72 million +52.3%N/A1.7 $1.67

PULM Short Interest - Frequently Asked Questions

What is Pulmatrix's current short interest?

Short interest is the volume of Pulmatrix shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 37,900 shares of PULM short. 1.04% of Pulmatrix's shares are currently sold short. Learn More on Pulmatrix's current short interest.

What is a good short interest ratio for Pulmatrix?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PULM shares currently have a short interest ratio of 1.0. Learn More on Pulmatrix's short interest ratio.

Which institutional investors are shorting Pulmatrix?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pulmatrix: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Pulmatrix?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.04% of Pulmatrix's floating shares are currently sold short.

Is Pulmatrix's short interest increasing or decreasing?

Pulmatrix saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 37,900 shares, an increase of 9.5% from the previous total of 34,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Pulmatrix's float size?

Pulmatrix currently has issued a total of 3,650,000 shares. Some of Pulmatrix's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pulmatrix currently has a public float of 3,650,000 shares.

How does Pulmatrix's short interest compare to its competitors?

1.04% of Pulmatrix's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Pulmatrix: Editas Medicine, Inc. (16.24%), Telomir Pharmaceuticals, Inc. (11.30%), Coherus BioSciences, Inc. (30.41%), Vaxart, Inc. (5.52%), OptiNose, Inc. (3.44%), Anixa Biosciences, Inc. (1.29%), Adverum Biotechnologies, Inc. (11.52%), Fate Therapeutics, Inc. (13.47%), Black Diamond Therapeutics, Inc. (13.89%), OncoCyte Co. (2.53%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Pulmatrix stock?

Short selling PULM is an investing strategy that aims to generate trading profit from Pulmatrix as its price is falling. PULM shares are trading down $0.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Pulmatrix?

A short squeeze for Pulmatrix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PULM, which in turn drives the price of the stock up even further.

How often is Pulmatrix's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PULM, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:PULM) was last updated on 4/6/2025 by MarketBeat.com Staff
From Our Partners